We are live on ! Find out more
NA

NewEdge Advisors Portfolio holdings

AUM $27.7B
1-Year Est. Return 22.98%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+22.98%
3 Year Est. Return
+69.07%
5 Year Est. Return
+86.55%
10 Year Est. Return
+264.51%
AUM
$8.85B
AUM Growth
+$851M
Cap. Flow
+$412M
Cap. Flow %
4.65%
Top 10 Hldgs %
16.84%
Holding
3,702
New
289
Increased
1,323
Reduced
1,138
Closed
218

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$30.8M
2
UL icon
Unilever
UL
+$28.5M
3
CMCSA icon
Comcast
CMCSA
+$27.6M
4
ITW icon
Illinois Tool Works
ITW
+$27.1M
5
MDLZ icon
Mondelez International
MDLZ
+$26.8M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$30.6M
2
ABT icon
Abbott
ABT
+$28.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$27.8M
4
DOV icon
Dover
DOV
+$27.1M
5
ULST icon
State Street Ultra Short Term Bond ETF
ULST
+$24.4M

Sector Composition

Rank Sector Weight
1 Technology 12.26%
2 Financials 5.78%
3 Healthcare 5.7%
4 Consumer Discretionary 4.46%
5 Industrials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAY
3251
DELISTED
Dayforce
DAY
$938 ﹤0.01%
14
-76
-84% -$4.89K
QQQH
3252
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$373M
$935 ﹤0.01%
22
GH icon
3253
Guardant Health
GH
$20.2B
$930 ﹤0.01%
26
-569
-96% -$16.3K
CPUH
3254
DELISTED
Compute Health Acquisition Corp.
CPUH
$928 ﹤0.01%
87
LKFN icon
3255
Lakeland Financial Corp
LKFN
$1.56B
$922 ﹤0.01%
19
XTN icon
3256
State Street SPDR S&P Transportation ETF
XTN
$388M
$921 ﹤0.01%
11
PUBM icon
3257
PubMatic
PUBM
$592M
$914 ﹤0.01%
50
AXGN icon
3258
Axogen
AXGN
$2.2B
$913 ﹤0.01%
100
STC icon
3259
Stewart Information Services
STC
$2.08B
$905 ﹤0.01%
22
SPXL icon
3260
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.59B
$900 ﹤0.01%
10
GLOB icon
3261
Globant
GLOB
$1.57B
$898 ﹤0.01%
+5
New +$820
CYH icon
3262
Community Health Systems
CYH
$391M
$880 ﹤0.01%
200
-300
-60% -$1.28K
QSI icon
3263
Quantum-Si Incorporated
QSI
$157M
$880 ﹤0.01%
492
GSEW icon
3264
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$1.89B
$875 ﹤0.01%
14
LFMD icon
3265
LifeMD
LFMD
$176M
$870 ﹤0.01%
200
GRCL
3266
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$865 ﹤0.01%
+227
New +$636
BIVI icon
3267
BioVie
BIVI
$10.8M
$862 ﹤0.01%
2
IONS icon
3268
Ionis Pharmaceuticals
IONS
$8.81B
$861 ﹤0.01%
21
+13
+163% +$500
LSPD icon
3269
Lightspeed Commerce
LSPD
$1.27B
$846 ﹤0.01%
50
MBIO icon
3270
Mustang Bio
MBIO
$4.5M
$845 ﹤0.01%
3
LIVE icon
3271
Live Ventures
LIVE
$29.6M
$838 ﹤0.01%
32
-6
-16% -$169
HYLN icon
3272
Hyliion Holdings
HYLN
$646M
$835 ﹤0.01%
500
PBI icon
3273
Pitney Bowes
PBI
$2.46B
$835 ﹤0.01%
236
ESPR
3274
DELISTED
Esperion Therapeutics
ESPR
$834 ﹤0.01%
600
-8,222
-93% -$11.5K
GSIT icon
3275
GSI Technology
GSIT
$224M
$829 ﹤0.01%
150
-34,274
-100% -$149K

Similar funds

NewEdge Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, NewEdge Advisors held 3,702 positions worth $8.85B, up 11% from $8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

NewEdge Advisors deployed $412M of net new capital in Q2 2023, opening 289 new positions and adding to 1,323 existing holdings. Its largest new stake was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Accenture, an estimated $30.6M trimmed.

  • NewEdge Advisors's largest Q2 2023 buy was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.
  • NewEdge Advisors added most to AbbVie in Q2 2023, an estimated $30.8M increase.
  • NewEdge Advisors's biggest Q2 2023 reduction was Accenture, cutting an estimated $30.6M.
  • NewEdge Advisors fully exited Quadratic Deflation ETF in Q2 2023, selling an estimated $3.13M.
  • NewEdge Advisors's ten largest holdings make up 17% of its $8.85B portfolio in Q2 2023.
  • NewEdge Advisors opened 289 new positions and closed 218 in Q2 2023.
  • NewEdge Advisors's portfolio value rose 11% quarter-over-quarter to $8.85B.

Based on NewEdge Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.